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Immunological tolerance may be operationally defined as a specific depression of the
immune response resulting from prior exposure to antigen . The mechanisms and the
cellular basis of tolerance induction vary with the experimental conditions under which
tolerance is induced . Chiller et al . (1) have demonstrated that tolerance can result from
specific inhibition of thymus-derived (T) lymphocytes or of both T lymphocytes and bone
marrow-derived (B) lymphocytes . Pure B-cell tolerance has been described after the
administration of a haptenic determinant conjugated to a nonimmunogenic carrier (2) . In
addition, recent work has suggested that some tolerance states may be mediated by the
activity of suppressor T cells (3) .
In the present paper, we will describe an experimental model for adult tolerance
induction which appears to be mediated by the production of small amounts of
high affinity antibody . It was found that a high degree of tolerance could be
induced in adult mice by a single intravenous, injection of antigen . The residual
plaque-forming cells (PFC)' present in partially tolerant animals contained a
larger subpopulation of cells producing very high affinity antibody than were
present in normal mice immunized simultaneously . Cells from the tolerant
animals transferred into lethally irradiated recipients yielded a response of
greater magnitude and higher avidity than that produced by cells from normal
mice transferred into irradiated animals . Tolerance was not abrogated by the
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injection of moderate numbers of normal spleen cells into tolerant mice . The
tolerant state showed a carrier specificity similar to that of passive antibody-
mediated immune suppression . These data are consistent with the hypothesis
that this tolerant state is mediated by the production of small amounts of high
affinity antibody in response to the tolerance-inducing injection of antigen . This
high affinity antibody causes a suppression of a subsequent immune response to
that antigen .
Materials And Methods
Mice .
￿
5- to 7-wk old LAF, male mice (Jackson Laboratories, Bar Harbor, Maine) were used .
Antigen and Hapten Preparation .
￿
Dinitrophenyl (DNP) derivatives of bovine gamma globulin
(BGG), rabbit serum albumin (RSA), and ovalbumin (Ova) were prepared by the reaction of
1-fluoro-2,4-dinitrobenzene (DNFB; Eastman Organic Chemicals Div., Eastman Kodak Co .,
Rochester, N. Y.) with the protein under alkaline conditions (4) . The products were purified by
extensive dialysis .
The concentrations of the derivatized proteins were calculated from their "dry weights" and the
degree of hapten substitution was estimated from their absorbancy at 360 nm (e for DNP-lysine -
17,400) . The DNP derivatives of BGG, RSA, and Ova had an average of 50, 30, and 14 DNP
groups/protein molecule, respectively .
Dinitrophenylated-e-amino-N-caproic acid (DNP-EACA) was prepared by the reaction ofDNFB
with EACA (Sigma Chemical Co ., St . Louis, Mo .) . Tritiated DNP-EACA was prepared by the
reaction of ['H]DNFB (Amersham/Searle Corp ., Arlington Heights, III.) and purified by thin-layer
chromatography . These methods have been described in detail previously (5) .
Immunization .
￿
Mice were immunized by the intraperitoneal injection of 0.4 mg DNP-BGG or
DNP-RSA emulsified in an equal volume of complete Freund's adjuvant (CFA ; 1 mg/ml Mycobacte-
rium butyricum) . A total vol of 0.2 ml of emulsion was injected .
Cell Transfer Studies .
￿
Spleens were teased apart in Hanks' balanced salt solution (HBSS; Grand
Island Biological Co ., Grand Island,N. Y.) and thesuspension filtered through athin layer of cotton
gauze . The cells were washed once with HBSS and resuspended in HBSS for intravenous injection
into lethally irradiated, syngeneic mice . The recipients, except as otherwise indicated, were
irradiated with 800 R from a cesium source (Gammator-G, Radiation Machinery Corp ., Parsippany,
N . J.) 2-4 h before cell transfer. Animals were immunized by the intraperitoneal injection ofantigen
in CFA 24h after cell transfer.
PFCAssay .
￿
PFC were assayed by the method of Kennedy and Axelrad (6) usingsheepredblood
cells (SRBC) coated with DNP-Ova by a chromic chloride technique (7). The washed DNP-Ova-cou-
pled SRBC were adsorbed as monolayers to poly-L-lysine (Miles Laboratories, Inc ., Miles Research
Div., Kankakee, Ill .) coated plastic petri dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) .
Spleens from experimental animals were teased apart, the cells washed once and resuspended in
HBSS containing 0.1 mg Na heparin/ml (Sigma Chemical Co .) . Guinea pig complement absorbed
with SRBC, was added at a final concentration of 10% (vol/vol) andthe cell suspension placed onto
theDNP-Ova-coupled SRBC monolayerand incubated at 37°C for 1 h. Plaqueswere counted usinga
dissecting microscope . Indirect PFC were developed by adding rabbit antimouse gamma globulin
(final dilution of 1:400) to the cell suspension . This concentration of developing antiserum inhibited
approximately 75% of direct PFC and resulted in maximum development of indirect PFC.
Determination ofPFC Avidity .
￿
The avidity of anti-DNP PFC was determined by inhibition of
plaque formation withDNP-EACA (8). Plaque formation by cellsproducinghigh avidity antibody is
inhibited by lowconcentrations of hapten whereas low avidity antibody-forming cells requireahigh
hapten concentration for inhibition . Thus, inhibition of plaque formation at a series of hapten
concentrations permits calculation of the distribution of avidities of the PFC. Nine hapten
concentrations, ranging from 1x 10-9 to 1 x 10-5 M, in one-half log increments, were used .
Measurement of Antibody Concentration and Affinity .
￿
Anti-DNP antibody concentration was
measured in mouse antiserum by a modification of the Klinman and Taylor immunoadsorbentGARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W. SISKIND
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method (9) . The affinity oftheantibody for [9H]DNP-EACA was assayed by the Farr technique (10) .
Thedetails of howthese procedures are performed in ourlaboratory have been previously reported (5,
11, 12) .
Preparation ofAnti-DNP-BGG Antibody .
￿
LAF, mice were injected intraperitoneally with 500Wg
ofDNP-BGG in CFA and boosted 6wk later by the intraperitoneal injection of 500AgDNP-BGG in
phosphate-buffered saline (PBS : 0.15M NaCl, 0.01M potassiumphosphate buffer, pH 7.4) . Animals
were bled 7 days later .
Induction, Duration, and Specificity of Tolerance .
￿
Micewere injected intrave-
nously with varying amounts of DNP-BGG in PBS or with PBS alone. 5 days
later, all animals received 0 .4 mgDNP-BGG in CFA, intraperitoneally . The mice
were sacrificed at various times thereafter, and their spleens assayed for the
number and avidity of anti-DNP PFC . 8 wk after immunization some animals
were boosted by the intraperitoneal injection of 0.4 mg DNP-BGG in PBS and
their spleens assayed for anti-DNP PFC 1 wk later .
The intravenous injection of DNP-BGG before immunization with DNP-BGG
in CFA resulted in a marked reduction in the number of anti-DNPPFC (Table 1) .
TABLE I
Induction of Tolerance to DNP-BGG in Adult Mice*
Time between
Results
* Mice were injected intravenously with the indicated dose ofDNP-BGG and were challenged with
0.4mgDNP-BGG in CFAintraperitoneally, when indicated . Results are expressed as thegeometric
means of groups of 5-7 mice .
$ Direct PFC/indirect PFC .
Tolerance-inducing
dose of DNP-
BGG
mg
tolerance induction
andantigen
challenge
days
Time between
antigen challenge
and sacrifice
days
Indirect anti-
DNPPFC
PFC/spleen
X10-1
5 7 147.1
0.02 5 7 46 .9
0 .5 5 7 26 .7
5.0 5 7 4.1
0.0 5 14 37 .8
0.02 5 14 18 .8
0.5 5 14 7 .8
5 .0 5 14 2.6
0.0 5 28 17 .6
0.02 5 28 8.5
0.5 5 28 3.3
5.0 5 28 0.9
0.0 14 7 18.7/168.7$
0.5 14 7 7.5/149 .7
5.0 14 7 4.4/45.1414
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The degree of depression (tolerance) was related to the amount of antigen
injected . The difference between tolerant and nontolerant groups was greatest at
1 wk after immunization and decreased thereafter as a consequence of a more
rapid decrease in the number of PFC in normal, as compared with tolerant
animals .
Tolerance induced with 0.5 mg DNP-BGG was of relatively short duration
(Table I) . By 2 wk after the intravenous injection of antigen the animals upon
immunization with DNP-BGG in CFA responded indistinguishably from con-
trols . In contrast, animals treated with 5 .0 mg DNP-BGG were still tolerant .
Specificity of the tolerant state was demonstrated by the observation (Table II)
Tolerance induction
TABLE II
Specificity of Tolerance to DNP-BGG*
Anti-SRBC PFC/ spleen x 10-'
DirectPFC
￿
IndirectPFC
-
￿
52 .3
￿
178.3
+
￿
41 .1
￿
148.9
*Animals were injected intravenously with 5.0 mg DNP-BGG or with PBS and were challenged 5
days laterwith 5 x 108 SRBC intravenously, Spleens were assayed for anti-SRBC PFC 1 wk later .
Results are expressed as the geometric means of groups of 7 mice .
that the intravenous injection of DNP-BGG had no effect on the immune
response to SRBC .
Effect of Tolerance on Avidity ofPFC and Affinity ofSerum Antibody .
￿
The
distribution of avidities ofPFC in normal and in tolerant animals is presented in
Fig . 1 . Normal animals initially had PFC of predominantly low avidity and
showed a progressive increase in avidity with time after immunization . In
contrast, early after immunization animals made tolerant by the intravenous
injection of 0.02 or 0.5 mgDNP-BGG had populations of higher avidityPFC than
did normal animals . This could be seen at 1 and at 2wk after immunization with
antigen in CFA. At 4 wk after intraperitoneal immunization all animalshadPFC
of equally high avidity . On the other hand, animals rendered tolerant by the
intravenous injection of5.0 mg DNP-BGG had only low avidity anti-DNP PFC
throughout the period of observation .
Antibody concentration and affinity were measured in the serum of a small
number of tolerant and normal animals (Table III) . As was observed at the PFC
level, animals made tolerant with 0.5 mg of antigen had higher affinity serum
antibody than did normal animals early after immunization . Animals tolerized
with 5 .0 mg of antigen had very low affinity serum antibody throughout the
period of observation. Thus, measurements on serum antibody confirm the
results described above on the avidity of antibody formed by PFC.
The high avidity of the residual PFC and serum antibody in animals rendered
tolerant by a low dose of soluble antigen is very different from previous studies in
which tolerance has been associated with decreased antibody affinity (13-18) .
This difference in results suggested that the tolerance being studied in the
present model is due to a distinctly different mechanism . Passive antibody isGARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W . SISKIND
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FIG . 1 .
￿
Each histogram illustrates the distribution of indirect anti-DNPPFC with respect to
avidity forDNP-EACA in thespleen of an individual mouse. Theabscissa represents the log of
the inverse of the hapten concentration used in the plaque inhibition assay . The ordinate
represents the percent of the total population ofPFC present in each subpopulation . Avidity
increases to the right . Counting from thetop down : rows 1 and 2 contain data on normal mice ;
rows 3and 4on mice tolerized with 0.02mgDNP-BGG; rows 5and6mice tolerized with 0.5 mg
DNP-BGG; and rows 7 and 8 mice tolerizedwith 5.0 mgDNP-BGG. Animals were immunized
with DNP-BGG in CFA 5 days after the tolerizing injection of antigen and sacrificed at the
time indicated below each column of histograms . Animals in the right most column were
boosted with DNP-BGG in PBS 8 wk after primary immunization .
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TABLE III
Effect of Tolerance Induction on Serum Antibody Affinity*
* Mice rendered tolerant by the intravenous injection of 0.5 or 5.0 mg DNP-BGG and immunized 5
days later with 0.4 mg DNP-BGG in CFA . Animals were bled at the times indicated . Antibody
concentration was determined by a solid-phase immunoadsorbent technique and affinity assayed
by the Farr technique using DNP-EACA as ligand .
$NM, not measurable .
known to cause a specific suppression in antibody synthesis with an increase in
the average affinity of the residual antibody (16, 19, 20) . It was, therefore,
hypothesized that, in the present model, tolerance induced by relatively low
doses of antigen was the result of the synthesis of small amounts of high affinity
antibody in response to the intravenous injection of antigen . This high affinity
antibody suppresses the immune response to antigen in CFA in a fashion
analogous to that of passively administered antibody .
Immune Response to Intravenous Antigen .
￿
If tolerance in the present system
is mediated by the production of small amounts of high affinity antibody in
response to the intravenous tolerizing injection of antigen, then one would expect
to detect an increase in PFC after the intravenous injection . As indicated in
7 0.16 8.93 0.14 9.08 0.05 NM$
0.11 9.30 0.06 9.78 0.05 NM
0.20 8.84 0.10 9.73 0.03 NM
0.23 8.83 0.04 NM
Average 0.18 8.98 0.10 9.53 0.04
14 0.52 9.58 - - 0.26 8.93
1.17 9.17 - - 0.15 8.57
0.95 9.27
Average 0.88 9.34 0.21 8.75
28 0.46 9.67 0.07 10.43
0.74 10.11 0.06 10.37
1.82 9.59 0.09 9.85
1.51 9.46 0.08 10.15
0.52 9.91 0.08 10.12
Average 1.01 9.75 0.08 10.18
56 1.10 10.14 - - 0.05 10.75
1.31 11.32 - - 0.25 8.82
1.86 9.85 - - 0.11 9.39
2.52 10.32 - - 0.16 9.62
1.53 10.30 - - 0.20 8.01
0.72 10.37 _
Average 1.51 10.38 0.15 9.32
Time after
Normal mice Tolerance (dose0.5 mg) Tolerance (dose 5.0 mg)
immuniza- Antibody Affinity Antibody
Affinity
Antibody
Affinity
tion concen-
-AF o I ioi,
concen-
-OF° i ~o
concen-
-OF° i iog~ tration tration tration
days mg/ml kcal/mol mg/ml kcal/mol mg/ml kcal/molGARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W. SISKIND
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Table IV, the injection of either 0.5 or 5.0 mg DNP-BGG elicited a significant
PFC response.
The distribution of avidities of PFC elicited by the intravenous injection of
antigen is shown in Fig. 2. A relatively high avidity population of PFC is already
present at 5 days after antigen injection. The avidity of the PFC present 5 days
after intravenous antigen is roughly comparable to the avidity of PFC 2 wk after
immunization with DNP-BGG in CFA (compare Fig. 1 and 2). Thus, the
intravenous injection of DNP-BGG stimulates a small but significant immune
response involving the selective proliferation of high avidity antibody-forming
cells.
Transfer of Normal Cells into Tolerant Animals.
￿
If tolerance results from the
production of high affinity antibody in response to the tolerance-inducing
Antigen dose
TABLE IV
Immune Response to Intrauenous DNP-BGG*
* Spleens were assayed for anti-DNP PFC 5days after the intravenous injection of the indicated dose
of DNP-BGG. Results are shown as the geometric means of groups of 5-7 mice.
Anti-DNP PFC/spleen x 10 -3
f
￿
' I
7
￿
9
Log 1/c
FIG. 2.
￿
Each histogram illustrates the distribution of indirect anti-DNP PFC with respect to
avidity for DNP-EACA in the spleen of an individual mouse 5 days after the intravenous
injection of 0.5 mg DNP-BGG. The abscissa represents the log of the inverse of the hapten
concentration used in the plaque inhibition assay. The ordinate represents the percent of the
total population of PFC present in each subpopulation. Avidity increases to the right.
Total PFC
40
20
11 n
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0 I ' - I - -I T --
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rng
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5.0 0.3 4.6418
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injection of antigen then one would expect that the injection of normal immuno-
competent cells into tolerant animals should not alter their unresponsive state. 3
days after the tolerizing injection of DNP-BGG, mice were irradiated with 360 R,
were given normal spleen cells intravenously, and were immunized 1 day later
with DNP-BGG in CFA. As indicated in Table V, injection ofnormal spleen cells
into tolerant animals did not alter their response to antigen. That is, the
responsiveness of normal spleen cells to DNP-BGG appeared to be blockedin the
tolerant animals . There was perhaps a slight tendency to overcome tolerance
induced with 5.0 mg of antigen when a high dose of spleen cells was used .
However, this effect was of small magnitude and only seen in the direct PFC
response . Thus, tolerance could not be terminated by injection of normal spleen
cells into tolerant mice . Furthermore, the tolerant state was not terminated by
the transfer ofnormal peritoneal exudate cells into tolerant animals (Table V) .
Transfer of Spleen Cells from Tolerant Animals into Normal Recipients .
￿
If
tolerance were due to the production of high affinity antibody one might predict
that cells from tolerant animals would transfer a high affinity, secondary type
response to lethally irradiated syngeneic mice . Cells from DNP-BGG tolerant
mice (transferred 5 days after tolerance induction) were capableof reconstituting
TABLE V
Effect of Transfer of Normal Cells into DNP-BGG Tolerant Mice*
* Mice were injected with the indicated dose ofDNP-BGG intravenously . 4 days later they received
360 R irradiation and the indicated number of normal, syngeneic, spleen, or peritoneal cells . 1 day
later all animalswere intraperitoneally immunizedwith 0.4 mgDNP-BGG inCFA . In exps . 1 and 2,
spleens were assayed 10 days after antigen challenge . In exp. 3 spleens were assayed 21 days after
antigen challenge . Results are expressed as the geometric means of groups of 5-7 mice .
$Peritoneal cells were obtained by washingthe peritoneal cavity of normal mice with HBSS .
Exp.
Tolerance-inducing
dose of DNP-BGG
Number
of cells
transferred
(x 10 8)
Anti-DNP
x
DirectPFC
PFC/spleen
10-3
Indirect PFC
Mg
1 (Spleen) 0.0 20 5 .2 27 .0
0.5 20 1 .2 12 .5
5 .0 20 0.6 1 .4
2 (Spleen) 0.0 70 7 .0 41 .5
0.0 None 2.3 33 .0
0.5 70 1.8 6.4
5.0 70 4 .2 4.2
3 (Spleen) 0.0 20 5.8 14 .3
0.5 20 2 .2 7.1
5.0 20 1 .2 2.8
4 (Peritoneal)$ 0.0 0 7 .6 98 .5
0.0 4 7.5 61 .5
5 .0 0 2 .1 7.0
5.0 4 1 .5 4.3GARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W. SISKIND
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the anti-DNP PFC response in such irradiated recipients (Table VI). In fact, the
responses of animals reconstituted with cells from tolerant donors were three- to
sevenfold greater than theresponses of animals receivingequal numbers of spleen
cells from normal donors.
If a 2-wk delay is imposed between tolerance induction and cell transfer,
spleens from mice tolerized with 0.5 mg DNP-BGG still showed an augmented
immune response as compared with normal spleen cells. In contrast, recipients of
spleens from mice injected with 5.0 mg DNP-BGG gave a PFC response identical
in magnitude to that of recipients of normal spleen cells.
TABLE VI
Transfer of Spleen Cells from DNP-BGG Tolerant Mice into Lethally Irradiated
Syngeneic Mice*
* Animalswere injected intravenously with the dose of DNP-BGGindicated. 5or 14 days later 2 x 10°
spleen cells from these mice were injected into 800Rirradiated, syngeneic recipients. All recipients
were immunizedwith 0.4 mg DNP-BGG in CFA, intraperitoneally, 1 dayafter cell transfer. Spleens
were assayed for anti-DNP PFC 10 days after immunization. The results are expressed as the
geometric means of groups of 5-7 animals.
The distribution of avidities of PFC in irradiated mice reconstituted with
spleen cells from tolerant or normal animals and immunized with DNP-BGG is
illustrated in Fig. 3. It is clear that the recipients of cells from tolerant animals
produce subpopulations of high avidity PFC which are not present in the
recipients of normal spleen cells.
Thus, the spleen cells from donors made tolerant with 0.5 mg DNP-BGG
behave as if they hadbeen primed to give asecondaryresponse upon transfer into
irradiated recipients. The response of animals reconstituted with cells from
tolerant donors is greater in magnitude and affinity than that of animals
reconstituted with normal spleen cells. The data are thus consistent with the
concept that the tolerance induced with 0.5 mg DNP-BGG is mediated by the
production of small amounts of high affinity antibody. When mice are made
tolerant with a larger dose of antigen (5 mg) a primed population of cells is
initially present. However, by 2 wk after tolerance induction with 5 mg
Exp.
Tolerance-inducing
dose ofDNP-BGG
Time before
transfer
Anti-DNP
Direct PFC
PFC/spleen x 10-3
Indirect PFC
mg days
1 0.0 5 1.9 6.2
0.5 5 3.1 21 .7
5.0 5 2.7 18.1
2 0.0 5 1 .7 3.9
0.5 5 3.1 28.8
5.0 5 4.5 21.6
3 0.0 14 0.2 0.4
0.5 14 2.5 21.6
5.0 14 0.2 0.5420
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%Total PFC
FIG. 3.
￿
Each histogram illustrates the distribution of indirect anti-DNPPFCwith respect to
avidity forDNP-EACA in the spleen of an individual lethally irradiated mouse reconstituted
with spleen cells from either normal mice or from mice made tolerant by the intravenous
injection of 0.5 or 5 .0 mgDNP-BGG 5 days before use as cell donors . The abscissa represents
the log of the inverse of the hapten concentration used in the plaque inhibition assay . The
ordinate represents the percent of the total population ofPFC present in each subpopulation .
Avidity increases to the right .The mice were immunized with DNP-BGG in CFA 1 day after
cell transfer and were sacrificed for assay 10 days after immunization .
DNP-BGG the spleen cells behave like cells from normal donors, suggesting that
additional factors are involved when tolerance is induced with larger doses of
antigen.
Carrier Specificity of Antibody-Mediated Suppression and of Tolerance .
￿
If
the tolerance described here results from the production of small amounts of high
affinity antibody, then passive antibody should duplicate both the effect on
affinity and the carrier specificity characteristics of this tolerance state . As
illustrated in Fig. 4, a low dose of passive antibody reproduces the effect on
avidity which is seen in the tolerant mice . That is, both antibody-mediated
suppression and the tolerance state studied here result in an increase in high
avidity PFC.
Serum antibody is known to exhibit significant carrier specificity (21) . The
carrier specificity of antibody-mediated immune suppression was thereforeGARY BIRNBAUM, MARC E . WEKSLER, AND GREGORY W . SISKIND
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FIG . 4 .
￿
Each histogram illustrates the distribution of indirect anti-DNPPFC with respect to
avidity forDNP-EACA in the spleen of an individual mouse . Theabscissa represents the log of
the inverse of the hapten concentration used in the plaque inhibition assay . The ordinate
represents the percentof the total population ofPFC present in each subpopulation . Avidity
increases to the right . The toprow received normal mouse serum (NMS) andthe bottom row
received mouse anti-DNP-BGG antiserum 1 day before immunization with 0.1 mgDNP-BGG
in CFA. Assays were carried out 7 days after immunization .
studied . Mice were given various doses of either mouse anti-DNP-BGG antibody
or normal mouse serum intraperitoneally . 1 day later all animals were immu-
nized intraperitoneally with either DNP-BGG or DNP-RSA in CFA and their
anti-DNPPFC responses were assayed 1 wk after immunization . Injection of0.05
ml of mouse anti-DNP-BGG antiserum markedly suppressed the immune
response to DNP-BGG but caused little suppression of the PFC response to
DNP-RSA (Table VII) . The carrier specificity of tolerance was then examined .
Mice made tolerant by the intravenous injection ofDNP-BGG were immunized5
days later with either DNP-BGG or DNP-RSA in CFA. DNP-BGG tolerant
animals showed a much greater depression in their response to DNP-BGG than
in their response to DNP-RSA (Table VIII) . This was true forboth the direct and
indirect PFC response . Thus, the tolerant state which wehave been studying and
antibody-mediated immune suppression both exhibit a similar marked degree of
carrier specificity .
Discussion
The data presented in this paper demonstrate that tolerance to a haptenic
determinant can be induced in adult mice by a single intravenous injection of
antigen . Tolerance produced by the intravenous administration of 0.5 mg
DNP-BGG appeared to result from the production of small amounts of high422
￿
ANTIBODY-MEDIATED TOLERANCE
TABLE VII
CarrierSpecificity ofImmune SuppressionAfterPassivelyAdministered
Anti-DNP-BGG Antibody*
Tolerance-
TABLE VIII
Carrier Specificity of Tolerance to DNP-BGG*
Direct anti-
￿
Indirect anti-
* Animalswere injected with 0.05 ml of mouse anti-DNP-BGG antiserum or with an equal volume of
normal mouse serum. 1 day later they were immunized intraperitoneally with 0.1 mg of either
DNP-BGG or DNP-RSA in CFA. Spleens were assayed 1 wk after immunization and the results are
expressed as the geometric means of groups of 5-7 mice.
* Mice were injected intravenously with the indicated dose of DNP-BGG. 5 days later the animals
were immunized intraperitoneally with 0.4 mg of either DNP-BGGor DNP-RSAin CFA. 1 wk after
immunization spleens were assayed for anti-DNP PFC and the results are expressed as the
geometric means of groups of 5-7 mice.
affinity anti-DNP-BGG antibody . This hypothesis is supported by several
observations. (a) Early after immunization tolerant animals have higher affinity
serum antibody and a population of higher avidity PFC than are present in
normal animals. It is known (16, 19, 20) that antibody-mediated immune
suppression is associated with an increase in affinity of the residual antibody. (b)
Animals only intravenously injected with DNP-BGG produced a significant
anti-DNP PFC response of high avidity. Thus, as has been shown previously (22),
intravenous antigen is capable of causing a selective proliferation of high avidity
inducing
dose of
DNA-BGG
Antigen
challenge
DNP
PFC/spleen
x 10-1
PFC
Depression
DNP
PFC/spleen
x 10-1
PFC
Depression
mg % %
0.0 DNP-BGG 10.3 - 114.6 -
0.0 DNP-RSA 3.9 - 27.2 -
0.5 DNP-BGG 1.1 89 19.7 83
0.5 DNP-RSA 3.3 15 18.6 32
5.0 DNP-BGG 1.4 86 2.7 98
5.0 DNP-RSA 3.2 18 9.1 67
Anti-DNP
antibody
treatment
Antigen
Direct
PFC/spleen
x 10-3
anti-DNP PFC
Depression
Indirect
PFC/spleen
x 10-s
anti-DNP PFC
Depression
- DNP-BGG 7.0 - 46.5 -
+ DNP-BGG 0.1 98 0.5 99
- DNP-RSA 1.5 - 6.9 -
+ DNP-RSA 0.8 47 8.9 NoneGARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W . SISKIND
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anti-DNP-producing cells . (c) Spleen cells from normal donors injected into
sublethally irradiated, tolerant mice did not respond to antigen suggesting that
their function was suppressed in the tolerant animals . (d) Spleen cells from
tolerant mice injected into lethally irradiated, syngeneic recipients produced a
PFC response of greater magnitude and higher avidity than that produced by
spleen cells from normal animals . The data suggest that the tolerizing injection
of antigen produces a selective proliferation of high affinity antibody-producing
cells so that upon cell transfer a high avidity secondary response is observed . (e)
The marked carrier specificity of the tolerant state was shown to be identical to
the carrier specificity of antibody-mediated immune suppression .
The ability of antibody to suppress immune responsiveness (23) and the effect of this
immune suppression on antibody affinity (16, 19, 20) have been well documented . It
appears that the major mechanism by which circulating antibody depresses the immune
response is, in effect, by competing with immunocompetent cells for available antigen .
This results in a preferential failure of stimulation of low affintiy antibody-forming cells .
Carrier specificity is generally regarded as characteristic of T-lymphocyte function . It
was therefore initially suprising to find that the tolerant state described here had a high
degree of carrier specificity . However, it must be remembered that serum antibody itself
has marked carrier specificity . Thus it has been shown (11) that antihapten antibody
binds the original immunizing hapten-protein conjugate with higher avidity than it binds
the hapten alone or the hapten on a different carrier . Since high affinity passive antibody
is far more effective in causing suppression than is low affinity antibody (24), and since
serum antibody has marked carrier specificity, one would predict that antibody-mediated
suppression should exhibit carrier specificity . This prediction was confirmed in the
present study . Thus, the carrier specificity of the tolerance state which we have been
studying is clearly consistent with the hypothesis that this tolerance is mediated by the
suppressive effects of circulating high affinity antibody .
Previous studies on the effect of tolerance on antibody affinity have suggested
that 13-lymphocyte tolerance mainly effects those cells which preferentially
capture antigen, that is, high affinity antibody-producing cells . Consequently,
B-cell tolerance has been found to be associated with a marked depression in
antibody affinity (13, 15-18) . The tolerant state described in the current work is
thus distinctive in that it is associated with an increase in antibody affinity . This
effect on affinity is consistent with the hypothesis that this form of tolerance is
mediated by high affinity circulating antibody formed in response to the
tolerizing injection of antigen .
It should be noted that the antigen preparation used for tolerance induction is a highly
substituted protein which has a tendency to aggregate and partially precipitate from
solution in normal saline at neutral pH . The antigen was not ultracentrifuged or
otherwise treated so as to remove aggregated protein before its use in tolerance induction .
Thus, the antigen preparation is one which would generally be regarded as highly
immunogenic . The preparation of antigen used in inducing the type of tolerance described
here is, therefore, quite different from antigen preparations freed of aggregated or
denatured material which have been previously shown to readily induce tolerance (25, 26) .424
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The tolerance described in the present paper thus appears to involve a stim-
ulation of high affinity antibody synthesis and results in an expanded popula-
tion of specific memory cells . It should be noted that upon subsequent anti-
gen injection high affinity memory cells, which arose in response to the initial
tolerizing injection of antigen, would be preferentially stimulated . High affinity
antibody would be promptly formed and would tend to suppress further antibody
synthesis . Crowle and Hu (27) have previously described what also appears to be
a state of antibody-mediated tolerance .
Tolerance induced by the intravenous injection of a 10-fold higher dose (5 .0
mg) of DNP-BGG, while sharing some similarities with the tolerant state
induced with lower doses of antigen, is different in several important respects .
The degree of tolerance was more marked and of longer duration after a 5.0-mg
dose of antigen than after lower doses . The avidities of PFC in animals tolerant to
a 5.0-mg dose of antigen were low and failed to increase with time . When spleen
cells from animals made tolerant with 5 .0 mg DNP-BGG were transferred to
irradiated recipients 2wk after the intravenous injection of antigen, they failed to
respond like spleen cells from mice tolerant to a 0.5-mg dose of antigen, but
responded instead like spleen cells from normal donors . Tolerance after 5.0 mg of
antigen must therefore involve at least two separate mechanisms . The first
mechanism is probably the production of anti-DNP-BGG antibody . This
conclusion is supported by the observations that there is a PFC response to the
injection of 5 .0 mg DNP-BGG and that normal spleen cells do not restore
responsiveness to tolerant animals . The second mechanism appears to be a
selective loss of high affinity anti-DNP antibody-producing cells . This hypothesis
is supported by : (a) the failure of PFC in animals tolerant to 5.0 mg doses of
antigen to increase in avidity with time after immunization ; (b) the longer
persistence of tolerance in these animals ; (c) the absence of a primed population
of PFC in spleens of animals tolerant to 5 .0 mg doses of antigen 2 wk after
tolerance induction . This initial production of antibody followed by a loss of high
affinity antibody-producing cells which occurs after injection of 5.0 mg of antigen
could result from an "exhaustive terminal differentiation" of antibody-producing
cells. Cells with high affinity antigen receptors would naturally be preferentially
affected by such a process. The loss of such populations of cell as a result of
"terminal differentiation" would leave the animals with a small population of
cells producing low affinity antibody . Such a mechanism for tolerance has been
postulated by Sterz (28) and by Sterz and Trnka (29) and seen to require the
injection of a large dose of antigen .
Summary
We have described a model of immunological tolerance induced, in adult mice,
by a single injection of a moderate dose of a hapten-protein conjugate . The data
suggest that the mechanism of this tolerance state is the production of small
amounts of high affinity antibody in response to the tolerance-inducing antigen
injection. This antibody acts to inhibit the response to a subsequent challenge
with antigen in complete Freund's adjuvant by a mechanism comparable to thatGARY BIRNBAUM, MARC E. WEKSLER, AND GREGORY W. SISKIND
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of passive antibody-mediated immune suppression. It was shown that a small
but high avidity PFC response occurs after the tolerizing injection of antigen .
The small number of PFC produced by partially tolerant mice are of high avidity
and their serum antibody is of high affinity . Tolerance was not terminated by
transfer of normal syngeneic spleen or peritoneal cells into tolerant animals .
Spleen cells from tolerant mice, when transferred into lethally irradiated,
syngeneic animals, produced a PFC response which is greater in magnitude and
of higher avidity than that produced by spleen cells from normal donors. The
tolerance state had a significant degree of carrier specificity which was shown to
be comparable to the carrier specificity of antibody-mediated immune suppres-
sion. Thus, evidence was presented to show that one mechanism of tolerance in
adult animals is the suppressive effect of small amounts of high affinity antibody
formed in response to the tolerizing injection of antigen .
Received for publication 25 September 1975.
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